XBiotech, Inc.
(NASDAQ : XBIT)

( )
XBIT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.81%67.011.0%$1018.93m
BIIBBiogen, Inc. 1.23%337.101.5%$697.83m
AMGNAmgen, Inc. -0.80%221.691.3%$576.64m
ILMNIllumina, Inc. 0.34%299.923.5%$431.18m
REGNRegeneron Pharmaceuticals, Inc. -0.48%397.652.6%$376.00m
VRTXVertex Pharmaceuticals, Inc. 0.87%245.931.9%$347.90m
ALXNAlexion Pharmaceuticals, Inc. -0.39%102.162.0%$209.65m
EXASEXACT Sciences Corp. 1.45%99.6024.0%$166.34m
AAgilent Technologies, Inc. -1.19%84.801.6%$153.01m
SGENSeattle Genetics, Inc. 1.61%119.976.1%$118.55m
MRNAModerna, Inc. -0.47%18.910.0%$109.05m
INCYIncyte Corp. 1.08%79.302.5%$101.80m
XLRNAcceleron Pharma, Inc. 0.69%94.316.1%$97.26m
SRPTSarepta Therapeutics, Inc. -2.11%122.7814.6%$93.77m
ALNYAlnylam Pharmaceuticals, Inc. -0.02%128.688.7%$93.35m

Company Profile

XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Humanâ„¢ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.